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Eighty percent of deaths from trauma occur within the first 24 
hours after injury.[1] Central nervous system (CNS) injuries and 
haemorrhagic shock are the leading causes of early mortality.[2] 
However, their respective prevalence may vary depending on trauma 
service and reporting. Despite advances in trauma care, uncontrolled 
haemorrhage is responsible for >50% of trauma-related deaths[2] and 
is the most common cause of preventable deaths.[3]
The significance of haemorrhage control cannot be over-
emphasised, as in addition to directly causing death, 25% of CNS 
injuries are complicated by shock, increasing CNS mortality two- 
to three-fold.[4-6] This relationship to early mortality ascribed to 
CNS injuries and haemorrhage remains consistent regardless of 
mechanism of injury.[2,7] Despite advances in trauma care, there are 
still few interventions that can directly improve outcome from severe 
primary CNS trauma.[8]
Haemorrhagic shock, however, is the leading cause of early 
poten tially preventable trauma deaths, and recognition of the acute 
coagulopathy of traumatic shock (ACoTS) has made this increasingly 
amenable to interventions that result in reductions in morbidity 
and mortality.[2,9-13] In association with major haemorrhage, acute 
coagulopathy on admission is reported to be associated with worse 
outcomes.[14]
Objectives
To assess the prevalence of ACoTS at the level 1 trauma unit at Inkosi 
Albert Luthuli Central Hospital (IALCH), Durban, South Africa 
(SA), and correlate it with injury severity and in-hospital mortality.
Methods
Study design
The study was approved by the local ethics review board (Biomedical 
Research Ethics Committee, University of KwaZulu-Natal, Durban, 
ref. no. BE131/09).
Study setting
The study was conducted in the level 1 trauma unit at IALCH 
during the years 2007 - 2011. The trauma unit receives patients either 
directly from the scene of the incident or via inter-hospital transfers. 
Patients’ hospital numbers were retrieved from the existing trauma 
unit database and used to access each individual patient record from 
the computerised hospital information system. We used Soarian 
(Siemens, Germany), which allows real-time data entry including 
patient demographics, clinical notes, and serological and radiological 
investigations. The first 1 000 patients admitted to the trauma unit were 
included in the study. The data were de-identified prior to assessment.
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morbidity and mortality.
Objectives. To assess the prevalence of coagulopathy in patients admitted to the level 1 trauma unit at Inkosi Albert Luthuli Central 
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scene). The mean INRs among survivors for all, scene and non-scene patients were 1.33, 1.30 and 1.34, respectively, and those among 
non-survivors 1.92, 2.01 and 1.88, respectively (p<0.001). The overall prevalence of coagulopathy was 48.7%, 46.9% in scene patients and 
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confidence interval (CI) 2.11 - 6.44; p<0.001) v. 25.1% for non-scene patients (aRR 1.67, 95% CI 1.15 - 2.05; p=0.004) (p=0.001).
Conclusions. There was a high prevalence of coagulopathy in our study. Raised admission INRs were associated with worse outcomes. 
There was a direct correlation between the INR and the ISS. INRs may offer predictive capabilities in resource-depleted environments where 
the ISS is not routinely calculated. Early recognition of acute coagulopathy may help reduce morbidity and mortality.
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The variables extracted included clinical parameters, mechanism of 
injury, INR, coagulation profile and in-hospital mortality. All blood 
results were those taken on admission to the resuscitation room 
via a direct-puncture arterial sample in a non-heparinised syringe. 
INR results were extracted from the electronic hospital laboratory 
database. The INR was analysed at the hospital laboratory using a 
Siemens BCS XP System (Siemens, Germany).[15] Innovin (Dade-
Behring, Germany) was the thromboplastin used. An INR >1.2 was 
considered indicative of coagulopathy, in accordance with previous 
studies.[16,17]
Missing blood results in the first hour of admission were excluded 
from the study. The mechanism of injury was obtained from the 
patient’s electronic chart. The Injury Severity Score (ISS)[18] was 
computed after all injuries had been identified using the Abbreviated 
Injury Scale 90 reference book.[19] Death or survival was ascertained 
from the electronic hospital discharge notes.
The data were processed and analysed using the R statistics 
program (R Core Team, 2014).[20] INRs were recorded and analysed 
in 939 patients. The INR was dichotomised into ≤1.2 and >1.2. 
These were then correlated with ISS and in-hospital mortality. 
The bivariate analysis employed Pearson’s χ2 test to determine the 
association between INR category and various outcomes/predictors, 
e.g. mortality. This analysis was then further stratified by scene/non-
scene. Furthermore, a multivariable Poisson regression with robust 
standard errors was performed to assess the relationship between 
coagulopathy and mortality after adjustment for age and gender. 
Coefficients were exponentiated to represent adjusted relative risks 
(aRRs). A p-value of <0.05 was considered statistically significant.
Results
Demographics
The first 1 000 patients were included in the study, of whom 752 were 
male (Table 1). The average age was 29 years (median 27, interquartile 
range (IQR) 21 - 36, standard deviation (SD) 15). The majority of 
admissions were from the 21 - 30-year age group (36.9%), with 1.6% 
aged >70 years and 16.5% <16 years.
Scene v. non-scene
There were 261 patients (26.1%) admitted directly from scene, the 
remaining 739 (73.9%) being inter-hospital transfers (non-scene).
INR in all admissions
INRs were not recorded in 61 patients, who were excluded from 
the analysis (Table 2). Of the remaining 939 patients, 454 (48.3%) 
were not found to have coagulopathy, while 485 (51.7%) had 
INRs >1.20. The overall mean INR was 1.46 (SD 1.77), (median 1.20, 
IQR 1.09 - 1.40). Survivors had significantly lower INRs (mean 1.33, 
median 1.18, IQR 1.07 - 1.33) than non-survivors (mean 1.92, med-
ian 1.35, IQR 1.14 - 1.68) (p<0.001).
The overall mortality rate was 21.9%, the rate being 15.4% in 
patients with a normal INR and 28.9% in those with a raised INR 
(p<0.001). Patients with an INR >1.20 were approximately two times 
more likely to die than those with a normal INR (adjusted RR 2.05, 
95% CI 1.60 - 2.63) (Table 3). This is higher than the crude estimate 
as a result of negative confounding from age, i.e. patients with 
coagulopathy were significantly younger than their counterparts, 
and older individuals were more likely to die. There was a trend of 
Table 1. Characteristics of the patients in the study 
Scene patients Non-scene patients
All patients
No coagulopathy
(INR ≤1.20)
Coagulopathy
(INR >1.20)
No coagulopathy
(INR ≤1.20)
Coagulopathy
(INR >1.20)
Patients, n 1 000 121/228 107/228 361/711 350/711
Age (years), mean (SD) 29 (15) 34 (15) 28 (16) 31 (15) 27 (15)
Males, n (%) 752 (75.2) 78 (64.5) 74 (69.2) 271 (75.1) 275 (78.6)
INR, mean (SD) 1.46 (1.77) 1.09 (0.07) 1.93 (2.61) 1.08 (0.08) 1.83 (2.44)
Coagulopathy prevalence, % 48.7 - 46.9 - 49.2
Mortality, % 21.9 12.4 41.1 16.3 25.1
ISS, median (SD)
All patients 25 (16) - - - -
Scene - 18 (14) 29 (20) - -
Non-scene - - - 22 (13) 25 (15)
Table 2. Incidence of coagulopathy and mortality for scene and non-scene patients according to ISS
ISS 0 - 15 ISS 16 - 30 ISS 31 - 45 ISS 46 - 60 ISS 61 - 75
Norm. Coag. Norm. Coag. Norm. Coag. Norm. Coag. Norm. Coag.
Scene (N=228)
n 45 14 48 42 20 27 4 14 2 12
Died, n (%) 1 (2.2) 1 (7.1) 6 (12.5) 9 (21.4) 4 (20.0) 12 (44.4) 3 (75.0) 12 (85.7) 1 (50.0) 10 (83.3)
Non-scene (N=711)
n 43 73 163 162 98 76 44 29 13 10
Died, n (%) 5 (11.6) 14 (19.2) 21 (12.9) 29 (17.9) 12 (12.2) 27 (35.5) 14 (31.8) 12 (41.4) 6 (46.2) 7 (70.0)
Norm. = no coagulopathy; Coag. = coagulopathy (INR >1.20).
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increasing deaths for each increase in INR 
interval (Fig. 1). The only INR interval with 
0% mortality was 0.80 - 0.89, suggesting that 
even within the so-called normal limits of the 
INR (0.8 - 1.2) patients are still vulnerable to 
adverse outcomes.
INR in scene patients
INRs were not recorded in 33 of the 261 
patients admitted directly from the scene. Of 
the remaining 228 patients, 121 (53.1%) did 
not have coagulopathy, while 107 (46.9%) 
had INRs >1.20. Survivors had signifi-
cantly lower INRs (mean 1.30, median 1.16, 
IQR  1.06 - 1.29) than non-survivors (mean 
2.01, median 1.42, IQR 1.21 - 1.73) (p=0.01). 
The overall mortality rate was 25.9%, patients 
with a normal INR having a 12.4% mortality 
rate while the rate in those with a raised INR 
was 41.1% (p<0.001). Scene patients with an 
INR >1.20 were approximately four times 
more likely to die than scene patients with a 
normal INR (aRR 3.59, 95% CI 2.12 - 6.06) 
(Table 3).
INRs in non-scene patients
There were 739 patients transferred from 
other hospitals, among whom the INR was 
not recorded in 28. Of the remaining 711 
patients, 361 (50.8%) had INRs with in normal 
limits and 350 (49.2%) had INRs  >1.20. 
Survivors had significantly lower INRs 
(mean 1.34, median 1.19, IQR  1.08 - 1.34) 
than non-survivors (mean 1.88, med ian 
1.30, IQR 1.13 - 1.64) (p<0.001). The overall 
mortality rate was 20.7%, patients with a 
normal INR having a 16.3% mortality rate 
while the rate in those with a raised INR was 
25.1% (p=0.004). Non-scene patients with an 
INR >1.20 were ~1.7 times more likely to die 
than non-scene patients with a normal INR 
(aRR 1.67, 95% CI 1.26 - 2.23) (Table 3).
Severity of injury
The ISS was calculated for each patient. The 
incidence of coagulo pathy increased as the 
ISS increased. The median overall ISS was 
25, being 20 for survivors (IQR  14 - 29) 
and 34 for non-survivors (IQR  25 - 50). 
The median ISS in scene patients who 
survived was 18 (IQR 9 - 28), the score for 
non-survivors being 50 (IQR 34 - 66). The 
mean ISS score for non-scene patients who 
survived was 22 (IQR 16  - 29) and that for 
non-survivors 30 (IQR 18 - 41).
Among scene patients, the lowest ISSs 
associated with coagulopathy were 16 - 30, 
with ISSs of 31 - 45 in non-scene patients. 
After adjusting for age and gender, increasing 
ISS was significantly associated with an 
increased risk of mortality among all patients 
as well as when stratified as scene/non-scene 
(Table 3). Overall a one-unit increase in 
ISS after adjustment was associated with an 
~4% increased risk of mortality (aRR 1.04; 
p<0.001). This effect size was similar when 
stratified by scene/non-scene.
Among patients who died, there was a 
greater degree of coagulo pathy for every 
ISS interval for both scene and non-scene 
patients. Table 2 illustrates the incidence 
of coagulopathy and mortality in scene 
and non-scene patients categorised by ISS. 
The presence of coagulopathy was also 
significant when deaths in resuscitation, in 
the operating theatre and within 24 hours of 
ICU admission were excluded (Fig. 2).
The majority of patients with an INR of 
<1.30 have a higher probability of being 
alive despite their injury severity. However, 
the INR interval 1.30 - 1.49 shows a pro-
gressively increased probability of death as 
the ISS increases. Patients with an INR >1.49 
have a high probability of death across all ISS 
intervals. In this study, the overall prevalence 
of coagulopathy was 34.1% for an ISS <15, 
47.3% for an ISS of 16 - 30, 57.1% for an 
ISS of 31 - 45 and 70.1% for an ISS >45. 
Both the scene and non-scene groups had 
an increased prevalence with increasing ISS 
scores.
Discussion
Invented by Kirkwood[21] in an effort to 
consistently record prothrombin ratios, the 
INR is the ratio of patient’s prothrombin 
time (PT) divided by the mean normal PT 
raised to the power of the International 
Sensitivity Index (ISI). Before the INR was 
available, many different prothrombin time 
Table 3. Multiple Poisson regression analysis for all, scene and non-scene patients, 
adjusted for age and male gender
INR model ISS model
Variable aRR 95% CI p-value Variable aRR 95% CI p-value
All INR >1.20 1.92 1.49 - 2.48 <0.001 ISS 1.04 1.03 - 1.04 <0.001
Age 1.02 1.01 - 1.03 <0.001 Age 1.02 1.01 - 1.02 <0.001
Male 1.10 0.83 - 1.46 0.516 Male 1.21 0.96 - 1.55 0.113
Scene INR >1.20 3.68 2.11 - 6.44 <0.001 ISS 1.04 1.03 - 1.05 <0.001
Age 1.01 1.00 - 1.02 0.017 Age 1.01 1.00 - 1.02 0.059
Male 0.97 0.62 - 1.50 0.884 Male 1.00 0.73 - 1.36 0.978
Non-scene INR >1.20 1.54 1.15 - 2.05 0.004 ISS 1.03 1.02 - 1.04 <0.001
Age 1.02 1.01 - 1.03 <0.001 Age 1.02 1.01 - 1.03 <0.001
Male 1.21 0.83 - 1.76 0.316 Male 1.40 0.98 - 2.01 0.062
0
Patients, %
≥2.20
IN
R 
in
te
rv
al
s
Alive
Dead2.00 - 2.19
1.80 - 1.99
1.60 - 1.79
1.50 - 1.59
1.40 - 1.49
1.30 - 1.39
1.20 - 1.29
1.10 - 1.19
1.00 - 1.09
0.90 - 0.99
0.80 - 0.89
  20  40   60   80   100   120
Fig. 1. INR intervals and associated outcomes.
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ratios were recorded based on the type of 
thromboplastin reagent used. Kirkwood[21] 
also produced the ISI, which allowed the 
calibration of different thromboplastins to an 
international standard. The INR is therefore 
a more precise way than other methods of 
accurately recording the prothrombin ratios 
and the degree of coagulation.
The INR and PT are measures of the 
extrinsic pathway of coagu lation. The 
PT measures the following clotting 
factors: factor I (fibrinogen), factor II, 
factor V, factor VII and factor X. The 
activated partial thromboplastin time 
(aPTT) measures factors VIII, IX and 
XII of the intrinsic pathway and factors 
V, X, fibrinogen and prothrombin of the 
common pathway. The INR/PT and aPTT 
are therefore screening tests for detecting 
critical clotting factor deficits that impair 
haemo stasis.[22]
Rizoli et al.[22] analysed clotting factor 
levels in patients with severe trauma (ISS 
≥16). They found that patients without a 
critical clotting factor deficiency all had 
normal INRs and aPTTs, i.e. that the INR 
and aPTT had a specificity of 100% for 
critical clotting factor deficits. [22] Factor V 
was found to be particularly low compared 
with other clotting factors.[22] They also 
noted that thromboelastography was inferior 
to INR or aPTT in identification of critical 
clotting factor deficits.[23] Critical clotting 
factor deficiencies occur immediately after 
injury, before substantial fluid resuscitation, 
and are associated with poor outcomes. 
At the time of our study, neither ROTEM 
products (TEM, Switzerland) nor a point-of-
care (POC) INR device were available in our 
unit. Our findings suggest that a raised INR 
is associated with increased mortality rates 
and that both the INR and the ISS can be 
used to identify patients at risk.
Incidence of ACoTS
The prevalence of coagulopathy in our 
study is higher than the rates reported by 
Brohi et al.[14] ACoTS is reported in 25% of 
trauma patients, with an associated four-fold 
increase in mortality.[14,24,25] Wafaisade et al.[26] 
and Maegele et al.[24] reported prevalence 
rates of coagulopathy at admission of 36.1% 
and 34.2%, respectively. Similar rates were 
seen in combat casualties.[27] In our study, 
the overall prevalence of coagulopathy was 
48.7%, with prevalences of 46.9% and 49.2% 
in scene and non-scene patients, respectively.
We further identified prevalence rates for 
each subgroup of ISS. There was an overall 
increased prevalence of coagulopathy as ISSs 
increased. This was true for both scene 
and non-scene patients. The mortality rate 
for patients with coagulopathy in each ISS 
category was higher than that for patients 
with no coagulopathy. However, among the 
non-scene patients the mortality rates for 
both patients with normal coagulation and 
those with coagulopathy were similar for 
each ISS category. This suggests that these 
patients may benefit from earlier direct 
referral to a level 1 trauma unit. In resource-
depleted environments and in regional 
and district hospitals where ISSs are not 
calculated, INRs may be used to identify 
high-risk patients.
Our results show that the incidence of 
coagulopathy was increased with increases 
in ISS. Increased tissue injury manifested by 
the ISS is related to a proportional increase 
in coagulopathy. The ISS risk ratio for the 
entire study population suggested that as 
the ISS increases, the risk of dying increases 
significantly.
Study limitations
INRs can be deranged in conditions other 
than trauma, including chronic liver disease, 
and as a result of anticoagulation therapies. 
The median age and IQR in our study 
suggests that these conditions were unlikely. 
Clotting tests were performed at 37oC and 
not at body temperature. Similar studies 
report similar limitations.[14,25,28] Further 
analysis of the non-scene group, including 
amount and type of fluid administration, 
could offer further insight into the increased 
prevalence of coagulopathy in this group.
Recommendations
While ISSs are also predictive of poor 
outcomes, these scores are not routinely 
calculated in regional and district hospitals. 
The INR may offer predictive capabilities 
to the attending doctor in resource-
depleted environments. POC devices offer 
the opportunity to obtain INRs faster than 
conventional coagulation tests.
Conclusions
ACoTS is often present in trauma patients, 
particularly the severely injured. The overall 
prevalence of coagulopathy was comparable 
to previous studies and was high in both 
direct admissions and inter-hospital transfers. 
Raised admission INRs were associated with 
worse outcomes. There was a direct correlation 
between INRs and ISSs. The INR may help 
identify patients at risk in resource-depleted 
environments. Further studies will assist in 
identifying optimal overall cut-off values for 
INR, ISS and ISS subgroups that would help 
identify patients at risk. Earlier recognition of 
ACoTS may help reduce mortality.
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